** Shares of genetic testing firm Tempus AI TEM.O fall 16.9% to $57.8 premarket
** Co posts Q4 revenue of $200.7 mln, missing analysts' estimates of $203.1 mln as per data compiled by LSEG
** TEM reports Q4 net loss of 18 cents/share vs analyst est of 20 cents/share
** Co forecasts 2025 revenue to be $1.24 bln; analysts on average expect annual revenue to be $1.04 bln
** Stock has risen 72.8% since its Nasdaq debut in June
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.